Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F13%3A10191886" target="_blank" >RIV/00216208:11130/13:10191886 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/13:10191886

Výsledek na webu

<a href="http://dx.doi.org/10.2147/PPA.S49113" target="_blank" >http://dx.doi.org/10.2147/PPA.S49113</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2147/PPA.S49113" target="_blank" >10.2147/PPA.S49113</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review

Popis výsledku v původním jazyce

Introduction and methods: Hepatitis C virus (HCV) infections are highly prevalent amongst people who inject drugs (PWID). Despite well documented evidence of its effectiveness, suggested cost-effectiveness, and potential to reduce HCV prevalence rates, the uptake of antiviral HCV treatment by PWID is low. This nonsystematic literature review describes factors associated with the uptake, adherence, and efficacy of HCV treatment among PWID and discusses strategies to increase their uptake of treatment. Results: Low HCV treatment uptake among PWID is associated with a number of patient-related and provider-related barriers. Beliefs and fears about low efficacy and adverse effects on the patient's part are common. A substantial number of factors are associated with the chaotic lifestyle and altered social functioning of PWID, which are often associated with decompensation or relapsing into drug addiction. This may lead to perceived low adherence with treatment and low efficacy on the provi

Název v anglickém jazyce

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review

Popis výsledku anglicky

Introduction and methods: Hepatitis C virus (HCV) infections are highly prevalent amongst people who inject drugs (PWID). Despite well documented evidence of its effectiveness, suggested cost-effectiveness, and potential to reduce HCV prevalence rates, the uptake of antiviral HCV treatment by PWID is low. This nonsystematic literature review describes factors associated with the uptake, adherence, and efficacy of HCV treatment among PWID and discusses strategies to increase their uptake of treatment. Results: Low HCV treatment uptake among PWID is associated with a number of patient-related and provider-related barriers. Beliefs and fears about low efficacy and adverse effects on the patient's part are common. A substantial number of factors are associated with the chaotic lifestyle and altered social functioning of PWID, which are often associated with decompensation or relapsing into drug addiction. This may lead to perceived low adherence with treatment and low efficacy on the provi

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FN - Epidemiologie, infekční nemoci a klinická imunologie

OECD FORD obor

—

Projekt

<a href="/cs/project/NS10034" target="_blank" >NS10034: Společenské náklady užívání tabáku, alkoholu a nelegálních drog v ČR 2007</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Patient Preference and Adherence

ISSN

1177-889X

e-ISSN

—

Svazek periodika

7

Číslo periodika v rámci svazku

Oct 17

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

9

Strana od-do

1067-1075

Kód UT WoS článku

000325679700001

EID výsledku v databázi Scopus

—